Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05160571 · ClinicalTrials.gov registry record

A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions

A clinical trial of Lung Cancer and Pulmonary Nodule, sponsored by Intuitive Surgical.

Completed
Registry status
279
Enrollment target
1
Study location

NCT05160571 is a study of Lung Cancer and Pulmonary Nodule that has completed, run by Intuitive Surgical. The registered enrollment target is 279 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05160571, a study of Lung Cancer and Pulmonary Nodule, has completed, sponsored by Intuitive Surgical.

COMPLETED
Registry status
279 participants
Enrollment target
1
Study location

Study Summary

This study is a retrospective multi-center chart review of patients who underwent an attempted biopsy of one or more pulmonary lesion(s) with the Ion Endoluminal System with the aim of assessing the overall performance of the system.

Interventions

  • DEVICE Ion Endoluminal System

Study Locations (1)

Virginia

  • Winchester Medical Center - Winchester

Trial Details

FieldValue
Enrollment Target 279 participants
Start Date 2021-11-01
Est. Completion 2022-12-31

Sponsor

Intuitive Surgical

40 total trials

What the Registry Record Tells You About NCT05160571

The ClinicalTrials.gov registry entry for NCT05160571 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (70% lower). The listed sponsor is Intuitive Surgical, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Ion Endoluminal System is the first listed.

NCT05160571 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05160571 about?

NCT05160571 is a clinical study titled "A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions". This study is a retrospective multi-center chart review of patients who underwent an attempted biopsy of one or more pulmonary lesion(s) with the Ion Endoluminal System with the aim of assessing the overall performance of the system.

What is the current status of trial NCT05160571?

This trial is currently completed. The enrollment target is 279 participants. The study started on 2021-11-01. Estimated completion is 2022-12-31.

What conditions does trial NCT05160571 study?

This clinical trial studies the following conditions: Lung Cancer, Pulmonary Nodule.

What interventions are being tested in trial NCT05160571?

The interventions under investigation include: Ion Endoluminal System (DEVICE).

Who is sponsoring clinical trial NCT05160571?

This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05160571 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.